FDA Rejects MDMA for PTSD Over Safety Concerns

An expert panel of the Food and Drug Administration reviewed finding from two phase 3 clinical trials looking at the use of MDMA-assisted therapy for the treatment of PTSD.
Healthline Daily News
June 6, 2024
FDA Rejects MDMA for PTSD Over Safety Concerns
 
READ ON
→
She Had a Stroke at 39. Her Uncommon Symptoms Delayed Treatment
 
READ ON
→
Benefits, Side Effects, and Dosage of B-Complex Vitamins
 
READ ON
→
Your FAQs Answered: The Link Between Eczema and Nausea
 
READ ON
→
MORE STORIES
RESOURCE FOR YOU
 
 
HEALTHLINE VIDEO
 
 
WATCH NOW  →
 
 
 
 
HEALTHLINE RESOURCE
 
What we're reading next
The Connection Between Psoriatic Arthritis and Genetics
6 Signs You May Get a Hidradenitis Suppurativa Flare-Up
Doctor Discussion Guide for Moderate or Severe Psoriasis
Does Medicare Cover Nursing Homes?
healthline
FB   Tiktok   TW   youtube   INSTA

No comments:

Post a Comment